No video

New Drug Therapies in Hypertrophic Cardiomyopathy

  Рет қаралды 169

Mayo Clinic

Mayo Clinic

2 ай бұрын

Drs. Jeffrey Geske and Paul Friedman discuss the evolving landscape of therapies from treatment of hypertrophic cardiomyopathy. The dialogue includes novel therapies (myosin inhibitors), the evolving role of septal reduction therapy, and exploring unanswered questions.
Topics Discussed:
• Hypertrophic Cardiomyopathy
• Myosin Inhibitors
• Septal Reduction Therapy

Пікірлер
WHO CAN RUN FASTER?
00:23
Zhong
Рет қаралды 42 МЛН
UNO!
00:18
БРУНО
Рет қаралды 4,9 МЛН
The Joker saves Harley Quinn from drowning!#joker  #shorts
00:34
Untitled Joker
Рет қаралды 66 МЛН
Top 200 Drugs | 2024
23:23
Michael Unger
Рет қаралды 49 М.
Hypertrophic Cardiomyopathy (HCM): Innovative Options for Treatment
14:55
Sports Cardiology for the General Cardiologist
24:38
Mayo Clinic
Рет қаралды 172
ERN GUARD-Heart webinar 19: Innovative therapy in HCM
59:51
ERN GUARD-Heart
Рет қаралды 260
Decoding Atherosclerosis: The clotting theory and seed oil toxicity | Dr Paul Mason | FOM23
26:20
Statins Explained in 10 Minutes (by a cardiologist)
9:56
Medlife Crisis
Рет қаралды 750 М.
WHO CAN RUN FASTER?
00:23
Zhong
Рет қаралды 42 МЛН